期刊文献+

唑来膦酸在一例多发性骨髓瘤患者中的应用

原文传递
导出
摘要 1病例介绍 患者女,80岁。因"腰背疼痛1年,加重1个月"入院。1年前患者因腰痛于当地医院行骨密度检查示"重度骨质疏松";胸腰椎X线片提示多发椎体压缩骨折。行"椎体成形术",术后疼痛完全缓解,生活自理。出院后患者间断予补钙及阿仑膦酸钠抗骨质疏松治疗。
出处 《华西医学》 CAS 2011年第7期1119-1119,共1页 West China Medical Journal
  • 相关文献

参考文献9

  • 1Zeimer H, Firkin F, Grill V, et al. A ssessm en t of cellular expression of parathyroid hormone-related protein mRNA and protein in multiple myeloma[J]. J Pathol, 2000, 192 (3): 336-341.
  • 2Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcernia of malignancy: a pooled analysis of two randomized, controlled clinical trials[J].J Clin Oncol, 2001, 19(2): 558-567.
  • 3Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases inpatients with breast cancer or osteolytic lesions of multiple myeloma: a phaseⅢ, double-blind, comparative trial [J]. Cancer J, 2001, 7(5) : 377-387.
  • 4Rosen LS, Gordon D, Kaminski M, etal. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double- blind, multicenter, comparative trial[J]. Cancer, 2003, 98(8): 1735-1744.
  • 5罗利琼,张丽娟,冯刚.唑来膦酸治疗多发性骨髓瘤骨痛的疗效[J].实用医学杂志,2010,26(17):3223-3224. 被引量:11
  • 6Santini D, Fratto ME, Vincenzi B, et al. Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities[J]. BioDrugs, 2004, 18 (4) : 269-278.
  • 7Heidenreich A, Ohlmann CH. Ibandronate its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease [J ]. Expert Rev Anticancer Ther, 2004, 4(6): 991-1005.
  • 8Ramaswamy B, Shapiro CL. Bisphosphonates in the prevention and treatment of bone metastases [J].Oncology (Huntingt), 2003, 17(9): 1261-1270.
  • 9金高娃,那仁图雅.唑来膦酸和帕米膦酸二钠治疗肿瘤骨转移性骨痛的比较研究[J].内蒙古医学杂志,2010,42(2):219-220. 被引量:4

二级参考文献13

  • 1白海涛,王椿.双膦酸盐类药物治疗多发性骨髓瘤[J].世界临床药物,2005,26(6):364-367. 被引量:2
  • 2王焰,沈志祥.多发性骨髓瘤骨病研究进展[J].上海医学,2007,30(3):214-216. 被引量:6
  • 3Rosen I, Gordon D, Tchekmedyian S, et al. Zoledronic acid vet - SHS placebo in the trreatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase Ⅲ, double - blind, randomized trial - the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group[J]. J Clin Oncol, 2003, 21 (16):3 150-3 157.
  • 4Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a Phase Ⅲ, double- blind, comparative trial [J].Cancer, 2001, 7 (5):377 - 387.
  • 5Lee S, Rosen. Long - term efficacy and s', ffety of zoledronic acid compared with pamidronate disodium in the treatment Of skeletal complications in patients with advanced multiple myeloma or breast carcinoma[J]. Cancer, 2003, 98(8) : 1 735 - 1 744.
  • 6Kyle R A, Rajkumar S V. Multiple Myeloma [J]. N Engl J Med, 2004,351(18) : 1860-1873.
  • 7Tassone P, Forciniti S, Galea E, et al. Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines [J]. Leukemia, 2000,14 (5) : 841.
  • 8Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronie acid [J]. J Pharmacol Exp Ther, 2002,302 ( 3 ) : 1055.
  • 9Kunzmann V, Bauer E, Feurle J, et al. Stimulation of gammadeha T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma [J]. Blood, 2000, 96(2) :384.
  • 10Barille S, Akhoundi C, Collette M, et al. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of pro MMP-2, and induction of MMP-1 by myeloma cells [J]. Blood, 1997,90(4) : 1649.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部